Search hospitals
>
Ontario
>
BARRIE
Royal Victoria Regional Health Centre
Claim this profile
BARRIE, Ontario L4M 6M2
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Colon Cancer
Conducts research for Pancreatic Cancer
106 reported clinical trials
8 medical researchers
Summary
Royal Victoria Regional Health Centre is a medical facility located in BARRIE, Ontario. This center is recognized for care of Breast Cancer, Lung Cancer, Colorectal Cancer, Colon Cancer, Pancreatic Cancer and other specialties. Royal Victoria Regional Health Centre is involved with conducting 106 clinical trials across 126 conditions. There are 8 research doctors associated with this hospital, such as Giulio Didiodato, MD, Adam Gladwish, MD, Christiaan S. Stevens, and Dr. Renee Hanrahan.
Area of expertise
Breast Cancer
Royal Victoria Regional Health Centre has run 29 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Royal Victoria Regional Health Centre has run 13 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Giulio Didiodato, MD
Royal Victoria Regional Health Centre
5 years of reported clinical research
Adam Gladwish, MD
Royal Victoria Regional Health Centre
6 years of reported clinical research
Christiaan S. Stevens
Royal Victoria Regional Health Centre
11 years of reported clinical research
Dr. Renee Hanrahan
Royal Victoria Regional Health Centre
6 years of reported clinical research
Clinical Trials running at Royal Victoria Regional Health Centre
Breast Cancer
Chronic Lymphocytic Leukemia
Prostate Cancer
Lung Cancer
Melanoma
Multiple Myeloma
Cervical Cancer
B-Cell Leukemia
Lymphoma
Colon Cancer
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting
2 awards
Phase 3
3 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Royal Victoria Regional Health Centre?
Royal Victoria Regional Health Centre is a medical facility located in BARRIE, Ontario. This center is recognized for care of Breast Cancer, Lung Cancer, Colorectal Cancer, Colon Cancer, Pancreatic Cancer and other specialties. Royal Victoria Regional Health Centre is involved with conducting 106 clinical trials across 126 conditions. There are 8 research doctors associated with this hospital, such as Giulio Didiodato, MD, Adam Gladwish, MD, Christiaan S. Stevens, and Dr. Renee Hanrahan.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.